FR2116256B1 - - Google Patents

Info

Publication number
FR2116256B1
FR2116256B1 FR7043274A FR7043274A FR2116256B1 FR 2116256 B1 FR2116256 B1 FR 2116256B1 FR 7043274 A FR7043274 A FR 7043274A FR 7043274 A FR7043274 A FR 7043274A FR 2116256 B1 FR2116256 B1 FR 2116256B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7043274A
Other languages
French (fr)
Other versions
FR2116256A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOBIO LAB
Original Assignee
SOBIO LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SOBIO LAB filed Critical SOBIO LAB
Priority to FR7043274A priority Critical patent/FR2116256A1/fr
Publication of FR2116256A1 publication Critical patent/FR2116256A1/fr
Application granted granted Critical
Publication of FR2116256B1 publication Critical patent/FR2116256B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
FR7043274A 1970-12-02 1970-12-02 Enteric - coated l-dopa - for treatment of parkinsonism with reduced gastrointestinal side-effects Granted FR2116256A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7043274A FR2116256A1 (en) 1970-12-02 1970-12-02 Enteric - coated l-dopa - for treatment of parkinsonism with reduced gastrointestinal side-effects

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7043274A FR2116256A1 (en) 1970-12-02 1970-12-02 Enteric - coated l-dopa - for treatment of parkinsonism with reduced gastrointestinal side-effects

Publications (2)

Publication Number Publication Date
FR2116256A1 FR2116256A1 (en) 1972-07-13
FR2116256B1 true FR2116256B1 (enExample) 1974-03-22

Family

ID=9065059

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7043274A Granted FR2116256A1 (en) 1970-12-02 1970-12-02 Enteric - coated l-dopa - for treatment of parkinsonism with reduced gastrointestinal side-effects

Country Status (1)

Country Link
FR (1) FR2116256A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3961041A (en) 1974-11-14 1976-06-01 Interx Research Corporation Effervescent enteric coated L-dopa formulation and method of using the same

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
IE56459B1 (en) * 1983-12-21 1991-08-14 Elan Corp Ltd Controlled absorption pharmaceutical formulation
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3961041A (en) 1974-11-14 1976-06-01 Interx Research Corporation Effervescent enteric coated L-dopa formulation and method of using the same

Also Published As

Publication number Publication date
FR2116256A1 (en) 1972-07-13

Similar Documents

Publication Publication Date Title
FR2116256B1 (enExample)
AU2044470A (enExample)
AU1146470A (enExample)
AU1473870A (enExample)
AU1833270A (enExample)
AU2017870A (enExample)
AU1326870A (enExample)
AU1336970A (enExample)
AU1517670A (enExample)
AU1716970A (enExample)
AU1343870A (enExample)
AU1581370A (enExample)
AU1189670A (enExample)
AU1872870A (enExample)
AU1832970A (enExample)
AU1789870A (enExample)
AU1879170A (enExample)
AU1689770A (enExample)
AU1603270A (enExample)
AU1591370A (enExample)
AU1247570A (enExample)
AU1974970A (enExample)
AU1881070A (enExample)
AU1235770A (enExample)
AU1918570A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse